Cytocare 532 (10 vials x 5 ml)

Cytocare 532 works through a dual mechanism: the high-concentration HA provides immediate mechanical smoothing and hydration, while the CT50 complex provides essential substrates for collagen synthesis. Unlike the lighter Cytocare 502, which focuses on prevention, the 532 version actively reverses structural defects through biological matrix repair.

This treatment is strictly contraindicated. No clinical safety data exists for multi-component revitalizing complexes during pregnancy. We defer all elective aesthetic treatments until after the nursing period has concluded to maintain peak safety standards.

The standard protocol involves an initial phase of 3 sessions, spaced 3 weeks apart, followed by maintenance every 3 months. Typically, one 5 ml vial covers the face and neck. Practitioners should evaluate if 0.5 ml of filler-like micro-dosing is sufficient for specific fine lines before proceeding with a global mesotherapy approach.

Common reactions include temporary redness, papules at the injection site, and potential purple bruising. These effects usually resolve within 24 to 48 hours. Patients should follow our expert aftercare guide to ensure optimal healing. Any persistent nodules should be reported to the clinic to rule out tissue irregularities.

Avoid alcohol for 24h before and 48h after the procedure. Alcohol is a vasodilator that can exacerbate post-injection swelling and significantly increase the risk of bruising at the numerous mesotherapy entry points.

The formulation contains 32 mg of non-crosslinked Hyaluronic Acid per 5 ml vial and the CT50 complex (Vitamins B1, B2, B3, B4, B5, B6, B7, B8, B9, B12, and 21 Amino Acids).